Publications by authors named "Ciara Freeman"

Claim this Profile
C
Cytopenias and infections following ciltacabtagene autoleucel in heavily pretreated relapsed or refractory multiple myeloma.
Danai Dima, Jennifer M Logue, Syed Hamza Bin Waqar, Lauren C Peres, Christelle M Colin-Leitzinger, Ciara L Freeman

Haematologica· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.
Matthew J Maurer, Vit K Prochazka, Tarec Christoffer El-Galaly, Christopher R Flowers, Diego Villa, Ciara L Freeman

J Clin Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fludarabine Lymphodepletion Exposure is Associated with Toxicities after Idecabtagene-Vicleucel in Relapsed/Refractory Multiple Myeloma: Real-World Experience from the US Myeloma Immunotherapy Consortium.
Karen Sweiss, Charlotte Wagner, Eric Anto, Tom Greene, Ryan Sun, Ciara Freeman

Transplant Cell Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing SEMA4A-directed CAR T cells to overcome low BCMA antigen density in multiple myeloma.
Francesco Di Meo, Francesca Albano, Annamaria Cesarano, Yunfei Wang, Brandon Kale, Ciara Freeman

Cancer Cell· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma cell identity escape drives resistance to anti-BCMA T-cell-redirecting therapy in multiple myeloma.
Francesco Maura, Ciara L Freeman, Kylee H Maclachlan, Marta Larrayoz Ilundain, Bachisio Ziccheddu

bioRxiv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-progression outcomes following BCMA-directed CAR T-cell therapy in myeloma: impact of extramedullary and paramedullary disease.
Ziad Abuhelwa, Fnu Amisha, Wenyi Fan, Gabriel De Avila, Doris K Hansen, Ciara L Freeman

Front Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential targeting in multiple myeloma: talquetamab, a GPRC5D bispecific antibody, as a bridge to BCMA CAR-T therapy.
Binod Dhakal, Othman S Akhtar, David Fandrei, Alexandria Jensen, Rahul Banerjee, Ciara Freeman

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population-Wide Introduction of Dose-Adjusted EPOCH-R In High-grade B-cell Lymphoma with MYC/BCL2 Rearrangements, DLBCL Morphology.
Waleed Alduaij, Laurie H Sehn, Jean-Nicolas Champagne, Brett Collinge, Susana Ben-Neriah, Ciara L Freeman

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Chimeric Antigen Receptor T-Cell Therapy on Fracture Risk of Patients With Multiple Myeloma.
Thien Huong N Huynh, Bryan A Clampitt, Chloe M Chose, Matthew D Nester, David M Joyce, Ciara L Freeman

J Am Acad Orthop Surg· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapy.
Mark B Meads, Xiaohong Zhao, David R Noyes, Praneeth Sudalagunta, Alexandra Achille, Ciara L Freeman

Blood· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced CAR-T cell function and mitochondrial fitness from earlier unfractionated stem cell product in multiple myeloma.
Ciara L Freeman, Julieta Abraham-Miranda, Meghan Menges, Reginald M Atkins, Jerald Noble

Mol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard-of-care idecabtagene vicleucel for relapsed/refractory multiple myeloma.
Surbhi Sidana, Nausheen Ahmed, Othman Salim Akhtar, Ruta Brazauskas, Temitope Oloyede, Ciara L Freeman

Blood· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma.
Khushali Jhaveri, Ram Thapa, Dalia Ercan, Aditi Saha, Jerald Noble, Ciara Freeman

Clin Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic biomarkers in MCL: insights from the SHINE trial on the impact of MCL35 score and TP53 mutation status.
Ciara L Freeman, Srimathi Srinivasan, Brendan Hodkinson, Sanjay Deshpande, Todd Henninger

Blood· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.
Doris K Hansen, Lauren C Peres, Danai Dima, Alicia Richards, Leyla Shune, Ciara L Freeman

J Clin Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma.
Rahul Banerjee, Alicia Richards, Shonali Midha, Aimaz Afrough, Faiz Anwer, Ciara L Freeman

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium.
Oren Pasvolsky, Danai Dima, Lei Feng, Wenli Dong, Tiffany Richards, Ciara Freeman

Blood Cancer J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-body MRI for a patient with progressive multiple myeloma.
Jonathan E Henning, Taiga Nishihori, Ciara Freeman, Alexander Lazarides, Jinming Song

BJR Case Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor burden quantified by soluble B-cell maturation antigen and metabolic tumor volume determines myeloma CAR-T outcomes.
Ciara L Freeman, Jerald Noble, Meghan Menges, Ricardo Villanueva, Justyn Y Nakashima

Blood· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of older adults and frail patients receiving idecabtagene vicleucel: a CIBMTR study.
Othman Salim Akhtar, Temitope Oloyede, Ruta Brazauskas, Aimaz Afrough, Hamza Hashmi, Ciara Louise Freeman

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702.
Rahul Banerjee, Amber R Fritz, Othman S Akhtar, Ciara L Freeman, Andrew J Cowan

Leukemia· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.
Doris K Hansen, Lauren C Peres, Danai Dima, Alicia Richards, Leyla Shune, Ciara L Freeman

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular adverse events and outcomes after anti-BCMA CAR-T for relapsed and refractory multiple myeloma.
Stefanie Palfi, Lauren C Peres, Himara Koelmeyer, Melissa Alsina, Rachid C Baz, Ciara Freeman

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature-expressing DLBCL.
Waleed Alduaij, Aixiang Jiang, Diego Villa, Brett Collinge, Susana Ben-Neriah, Ciara L Freeman

Blood· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Haploidentical Stem Cell Transplant Recipients With HHV-6B Reactivation.
Guy Handley, Amanda Yepes, Eva Eliassen, Gabriel Dominguez, Yanina Pasikhova, Ciara L Freeman

Open Forum Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis